Research on Health Care for Priority Populations

Health Care for Minorities,Women, and Children

The agency's research emphasizes the needs of priority populations who generally are underserved by the health care system and underrepresented in research. Disparities in health care have been well-documented in recent decades across a broad range of medical conditions and for a wide range of populations, including racial and ethnic minorities, women, and children.

Disparities persist in health and health care for these groups, even though health care for the Nation as a whole has improved. For example:

AHRQ has established the Office for Priority Populations Research to coordinate, support, manage, and conduct health services research on priority populations. AHRQ has a long history of conducting and supporting research on health status and health care for priority populations. Since 1999, AHRQ has funded more than 200 grants and contracts specifically related to health disparities. AHRQ is continuing a major effort, begun several years ago, to identify underlying causes of inequities in care and develop and test quality measures and quality improvement strategies that can be used to address health care disparities.

AHRQ is developing the first-ever report on prevailing disparities in health care delivery in the United States. Recent reauthorization legislation directed AHRQ to prepare and publish this report annually, beginning in 2003. This effort will be carried out in partnership with other agencies to ensure compatibility with other existing projects, including AHRQ's National Healthcare Quality Report, also in progress, Healthy People 2010, and the Department's survey integration priorities. The National Healthcare Disparities Report (NHDR) will begin to provide comprehensive answers to critical questions about disparities in health care, such as:

  1. Are death rates for some inpatient procedures higher for members of certain racial/ethnic groups than for others?
  2. Are blacks or Hispanics less likely than whites to receive necessary services?
  3. Are uninsured patients more likely to receive surgery in hospitals with higher rates of medical errors?

Select for more information in this report about the NHDR.

Return to Contents

Minority Health

AHRQ has been investigating minority health issues for more than three decades. These investments in minority health services research have resulted in numerous findings that are helping us to understand the disparities experienced by racial and ethnic minorities, uncover the reasons for the disparities, and identify effective strategies for overcoming and eliminating racial/ethnic disparities.

In FY 2002, AHRQ funded about $50 million in research with a major emphasis on minority health. This effort includes continued funding of the Excellence Centers to Eliminate Ethnic/Racial Disparities (EXCEED) grants, a research effort to improve our understanding of the factors that contribute to ethnic and racial inequities in health care.

Other current AHRQ research projects focused on ways to eliminate racial disparities in health care include:

Racial/Ethnic Disparities and HIV

A nationwide study sponsored by AHRQ found that black and Hispanic patients with HIV are only about half as likely as non-Hispanic white patients to participate in clinical trials of new medications intended to slow progression of HIV.

Together, blacks and Hispanics comprise nearly half (48 percent) of the HIV population—33 percent of patients are black and 15 percent are Hispanic. Yet only 10 percent of black patients and 11 percent of Hispanic patients had participated in an HIV clinical trial, compared with 18 percent of white HIV patients. Also, black patients who did participate were more likely than other patients to drop out of the research.

These findings underscore the need to increase the diversity of trial populations. To do so, we must carefully consider research-entry criteria, enrollment and tracking procedures, and study center operations, as well as researchers' attitudes and practices. Other factors include patients' educational levels, type of insurance, and the distance patients must travel to the clinical trial site.

Examples of recent findings from AHRQ-supported research in this area include:

Return to Contents

Women's Health

AHRQ supports research focused on improving quality, achieving better outcomes, and enhancing access to effective health care for women. One specific focus of AHRQ's women's health agenda is research that enhances active life expectancy for older women. Although women in the United States are living longer than ever before, on average they experience 3.1 years of disability at the end of life. Today, heart disease, cancer, and stroke account for more than 60 percent of deaths among American women; more than one-third of deaths among women are due to heart disease.

Although we have made progress in early diagnosis and treatment of breast cancer, this disease continues to take a heavy toll on American women, particularly older women. Approximately 185,000 new cases of breast cancer are diagnosed among U.S. women each year, and nearly 45,000 women die from the disease.

AHRQ conducts and supports research on all aspects of health care provided to women, including studies that examine the differences in patterns of care between men and women. AHRQ is collaborating with the National Institutes of Health, Office of Research on Women's Health, in the Building Interdisciplinary Research Careers in Women's Health program to include a health services research component in support of the interdisciplinary focus of the programs to be developed.

AHRQ's women's health research agenda supports studies that are designed to:

Examples of AHRQ-funded women's health research currently underway include:

Return to Contents

Breast and Cervical Cancer

Examples of recent findings from AHRQ research on breast and cervical cancer include:

Selected Findings from AHRQ-Supported Studies on Women's Health

  1. The incidence of coronary heart disease in women has increased over the past decade, yet evidence suggests that women typically receive fewer high technology cardiac procedures than men. Before age 75, women are more likely than men to die in the hospital after a heart attack.
  2. ER doctors misdiagnose about 2 percent of patients with heart attack or stable angina because they do not have chest pain or other symptoms typically associated with heart attack. When these patients are mistakenly sent home from the ER, they are twice as likely to die from their heart problems as similar patients who are admitted to the hospital.
  3. Blacks and women have statistically significant lower odds of being referred for cardiac catheterization than whites and men.

Return to Contents

Domestic Violence

Another major focus for AHRQ's research on women's health involves studies to improve the response of health care organizations and clinicians to victims of domestic violence, the second leading cause of injuries and death among women of childbearing age. Estimates are that 2 percent to 4 percent of all women seen in hospital emergency departments have acute trauma associated with domestic violence, and another 10 to 12 percent of women have a recent history of domestic violence. Although most injuries sustained as a result of domestic violence are classified as superficial, an estimated 73,000 hospitalizations and 1,500 deaths among women are attributed to domestic violence every year. Direct health care costs associated with domestic violence are estimated to be $1.8 billion per year.

Examples of AHRQ activities focused on domestic violence include:

AHRQ Tool Helps Hospitals Assess Their Domestic Violence Programs

AHRQ recently announced the availability of a new evaluation instrument that hospitals can use to assess the quality and effectiveness of their domestic violence screening and intervention programs. The tool asks 38 questions and provides guidance to hospitals in assessing their programs.

Hospitals can use this instrument to find out how well they are doing in:

  1. Training clinicians to recognize domestic violence.
  2. Screening patients to determine risk and potential for future injury.
  3. Intervening, including medical treatment, victim advocacy services, and followup.

The tool was developed by AHRQ's Domestic Violence Senior Scholar-in-Residence in collaboration with the Family Violence Prevention Fund. Many nationally known experts in the field provided their expertise to the project, and the tool has been extensively field-tested.

The instrument and instructions for its use are available from AHRQ in print and on the agency's Web site at www.ahrq.gov/research/domesticviol/.

In FY 2002, AHRQ continued four research projects begun in FY 2000 to evaluate health system responses to domestic violence. These studies are the first of their kind and move beyond studying prevalence, screening, and training to take a rigorous look at a variety of health care interventions for domestic violence and their effectiveness. Women are being evaluated over time to identify interventions that improve their health and safety, predict and improve health care use, prevent and reduce the occurrence of domestic violence, and develop better techniques to identify women at risk for domestic violence.

Return to Contents

Children's Health

Children and adolescents are growing and developing, and their health care needs, use of services, and outcomes are very different from those of adults. Unlike adults, children and adolescents usually are dependent on parents and others for access to care and evaluations of the quality of that care. Furthermore, adolescents differ from younger children. They are moving from childhood to adulthood and have their own unique health care needs, preferences, and patterns of use.

Improving outcomes, quality, and access to health care for America's 70 million children and adolescents is a continuing priority for AHRQ. This special research focus is necessary if we are to realize improvements in the health care provided to young people of all ages.

AHRQ's work helps to fill the major gap that exists in evidence-based information on the health care needs of children and adolescents. Such information is essential to appropriately guide clinical and policy decisions. A special urgency was created with implementation of the State Child Health Insurance Program (SCHIP) and our need to have better information about children's health status, their needs, and their outcomes.

To address the scarcity of quality measures for children, AHRQ is supporting the development, testing, and implementation of the new Pediatric Quality of Life Measure. Also, the National Committee for Quality Assurance adopted the children's component of AHRQ's CAHPS® survey for inclusion in HEDIS®. CAHPS® is the first health-plan-oriented survey of children to be administered nationwide. The CAHPS® measure now permits users to distinguish quality of care for children with chronic illnesses and disabilities.

In FY 2002, AHRQ is supporting child-relevant studies focused on outcomes, quality and patient safety, the use and cost of care, and access to care. Researchers involved in these studies are working to:

Examples of recent findings from AHRQ-supported research on children's health issues include:

Selective testing finds most urinary tract infections in infants. The current recommendation is that doctors test the urine of all febrile infants younger than 3 months for urinary tract infection (UTI). Instead, many physicians test the urine of young infants with fever according to their clinical judgment rather than routinely.

Although this differs from the recommendations, a recent AHRQ study found few late diagnoses of UTIs among more than 800 infants whose urine was not initially tested and who were not initially treated with antibiotics. According to the researchers, doctors tend to order urine tests selectively, focusing on younger and more ill-appearing febrile infants and those who have no apparent fever source.

They studied the urine testing practices of 573 pediatricians from 219 practices who evaluated and treated 3,066 infants 3 months or younger with a temperature of 100.4ºF or higher. Over half (54 percent) of the infants initially had their urine tested, and 10 percent of those tested had a UTI. Among 807 patients not initially tested or treated with antibiotics, only 2 had a subsequent documented UTI, and both did well. Male infants who were not circumcised had nearly 12 times the likelihood of UTI, females had 5 times the likelihood of UTI, compared with circumcised infants, and infants with a fever lasting 24 or more hours had 80 percent greater odds of developing UTI.

The researchers conclude that urine testing should focus on uncircumcised boys, girls, the youngest (bacteremia rates among infants with a UTI ranged from 6 percent in 2-3 month-old infants to 17 percent in infants younger than 1 month) and sickest infants, and those with persistent fever.

Return to Contents
Proceed to Next Section